Treatment and prophylaxis of cytomegalovirus infection after bone marrow transplantation.

[1]  J. Niland,et al.  A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants , 1991 .

[2]  H. Einsele,et al.  Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. , 1991, Blood.

[3]  M. Pepe,et al.  Cytomegalovirus infection after marrow transplantation for aplastic anemia. , 1990, Bone marrow transplantation.

[4]  K. Sullivan,et al.  Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. , 1990, The New England journal of medicine.

[5]  D. Snydman,et al.  Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease. , 1990, Reviews of infectious diseases.

[6]  P. Ljungman,et al.  Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. , 1990, The Journal of infectious diseases.

[7]  J. Meyers,et al.  COMPARISON OF INTERLEUKIN 2 AND GAMMA‐INTERFERON PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS IN RESPONSE TO CYTOMEGALOVIRUS AFTER MARROW TRANSPLANTATION , 1990, Transplantation.

[8]  P. Ruutu,et al.  Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant recipients without pneumonia. , 1990, Annals of internal medicine.

[9]  R. Miller,et al.  Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger? , 1990, The American review of respiratory disease.

[10]  J. Meyers,et al.  Cytomegalovirus infection after autologous bone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment. , 1990, Blood.

[11]  A. Schreiber,et al.  Human anti-mouse immunoglobulins in sera of patients treated chronically with monoclonal antibody-purified factor VIII. , 1990, Seminars in hematology.

[12]  J. Meyers.  Prevention of cytomegalovirus infection after marrow transplantation. , 1989, Reviews of infectious diseases.

[13]  J. Booth,et al.  Discordant results obtained on testing sera from immunocompromised patients for cytomegalovirus IgG by enzyme-linked immunosorbent assay and radioimmunoassay. , 1989, Journal of virological methods.

[14]  A. Nademanee,et al.  Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. , 1988, Transplantation.

[15]  E. Reed,et al.  Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. , 1988, Annals of internal medicine.

[16]  D. Stover,et al.  Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. , 1988, Annals of internal medicine.

[17]  W. Drew,et al.  Diagnosis of cytomegalovirus infection. , 1988, Reviews of infectious diseases.

[18]  P. Burke,et al.  Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation , 1988 .

[19]  M. Thornquist,et al.  Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. , 1988, The New England journal of medicine.

[20]  M. Sayers,et al.  Cytomegalovirus‐seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks , 1987, Transfusion.

[21]  J. Shanley,et al.  IS CYTOMEGALOVIRUS INTERSTITIAL PNEUMONITIS IN TRANSPLANT RECIPIENTS AN IMMUNOPATHOLOGICAL CONDITION? , 1987, The Lancet.

[22]  E. Reed,et al.  Efficacy of cytomegalovirus immunoglobulin in marrow transplant recipients with cytomegalovirus pneumonia. , 1987, The Journal of infectious diseases.

[23]  P. Ruutu,et al.  Failure to prevent cytomegalovirus infection by cytomegalovirus hyperimmune plasma: a randomized trial by the Nordic Bone Marrow Transplantation Group. , 1987, Bone marrow transplantation.

[24]  Joel Meyer,et al.  NATURAL CYTOTOXIC ACTIVITY AGAINST CYTOMEGALOVIRUS‐INFECTED TARGET CELLS FOLLOWING MARROW TRANSPLANTATION , 1987, Transplantation.

[25]  M. Jacobson,et al.  Hemophilus influenzae type B cellulitis in an adult. , 1987 .

[26]  G. D. de Gast,et al.  Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation. , 1987, Bone marrow transplantation.

[27]  R. Gale,et al.  Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. , 1987, Annals of internal medicine.

[28]  G. Gahrton,et al.  Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro. , 1986, Bone marrow transplantation.

[29]  F. Appelbaum,et al.  Interstitial pneumonitis following autologous bone marrow transplantation. , 1986, Transplantation.

[30]  E. Reed,et al.  Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids. , 1986, Annals of internal medicine.

[31]  N. Flournoy,et al.  Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. , 1986, The New England journal of medicine.

[32]  N. Flournoy,et al.  Risk factors for cytomegalovirus infection after human marrow transplantation. , 1986, The Journal of infectious diseases.

[33]  A. Rimm,et al.  Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. , 1986, Annals of internal medicine.

[34]  P. de Miranda,et al.  Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia. , 1985, Annals of internal medicine.

[35]  E. Rosenow,et al.  Pulmonary complications of bone marrow transplantation. , 1985, Chest.

[36]  O. Ringdén,et al.  Acyclovir prophylaxis in bone marrow transplant recipients. , 1985, Scandinavian journal of infectious diseases. Supplementum.

[37]  M. Miller,et al.  Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation. , 1985, Annals of internal medicine.

[38]  B. L. Cardozo,et al.  Interstitial pneumonitis following bone marrow transplantation: pathogenesis and therapeutic considerations. , 1985, European journal of cancer & clinical oncology.

[39]  D. Shepp,et al.  Intravenous lymphoblastoid interferon and acyclovir for treatment of cytomegaloviral pneumonia. , 1984, The Journal of infectious diseases.

[40]  O. Ringdén,et al.  DECREASED INCIDENCE OF VIRIDANS STREPTOCOCCAL SEPTICAEMIA IN ALLOGENEIC BONE MARROW TRANSPLANT RECIPIENTS AFTER THE INTRODUCTION OF ACYCLOVIR , 1984, The Lancet.

[41]  J. Zaia,et al.  Prolonged human cytomegalovirus viremia following bone marrow transplantation. , 1984, Transplantation.

[42]  N. Flournoy,et al.  Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. , 1982, Reviews of infectious diseases.

[43]  J. Connor,et al.  Treatment of cytomegalovirus pneumonia with high-dose acyclovir. , 1982, The American journal of medicine.

[44]  R. Yolken,et al.  Infectious gastroenteritis in bone-marrow-transplant recipients. , 1982, The New England journal of medicine.

[45]  P. Greenberg,et al.  Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twins. , 1982, Transplantation.

[46]  P. Neiman,et al.  Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation. , 1980, The Journal of infectious diseases.

[47]  P. Neiman,et al.  A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. , 1977, The Journal of infectious diseases.

[48]  R. Mulcahy,et al.  PRIMARY PREVENTION , 1975, The Lancet.